Co-expression of trypsin and tumour-associated trypsin inhibitor (TATI) in colorectal adenocarcinomas

Histology and Histopathology

Volumn 18, Issue 4, 2003, Pages 1181-1188

  Solakidi, S ^a   Tiniakos, D G ^b   Petraki, K ^c   Stathopoulos, G P ^d   Markaki, I ^b   Androulakis, G ^c   Sekeris, C E ^a  

^a INSTITUTE OF BIOLOGY   (Greece)

^b UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^c UNIVERSITY OF ATHENS   (Greece)

^d HIPPOKRATION HOSPITAL   (Greece)

Author keywords

Gastrointestinal neoplasms; Immunohistochemistry; Kazal pancreatic; RT PCR; Trypsin inhibitor

Indexed keywords

APROTININ; MESSENGER RNA; PROTEINASE; PROTEINASE INHIBITOR; TRYPSIN;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; CANCER CELL; COLON MUCOSA; COLORECTAL CARCINOMA; CONTROLLED STUDY; CYTOPLASM; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; METASTASIS; PANCREAS; PARALLEL DESIGN; PROTEIN EXPRESSION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RECTUM MUCOSA; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STATISTICAL ANALYSIS; TISSUE LEVEL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELLS, CULTURED; COLON; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; ISOENZYMES; MALE; MIDDLE AGED; NEOPLASM STAGING; PARAFFIN EMBEDDING; RECTUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, NEOPLASM; TRYPSIN; TRYPSIN INHIBITOR, KAZAL PANCREATIC;

EID: 0142063056     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Bernard-Perrone F., Carrere J., Renaud W., Moriscot C., Thoreux K., Bernard P., Servin A., Balas D. and Senegras-Balas F. (1998). Pancreatic trypsinogen I expression during cell growth and differentiation of two human colon carcinoma cells. Am. J. Physiol. 274, G1077-G1086.
2. Bohe H., Bohe M., Lindstrom C. and Ohlsson K. (1990). Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in normal and neoplastic colonic mucosa. J. Clin. Pathol. 43, 901-904.
3. Bohe H., Bohe M., Lindstrom C. and Ohlsson K. (1991). Immunoreactive pancreatic secretory trypsin inhibitor in normal, inflammatory and neoplastic gallbladders. Gastroenterol. Jpn. 26, 95-98.
4. Egeblad M. and Werb Z. (2002). New functions for the matrix metalloproteinases in cancer progression. Nat. Rev. Cancer 2, 161-74.
5. Freeman T.C., Playford R.J., Quinn C., Beardshall K., Poulter L., Young J. and Calam J. (1990a). Pancreatic secretory trypsin inhibitor in gastrointestinal mucosa and gastric juice. Gut 31, 1318-1323.
6. Freeman T.C., Curry B.J., Calam J. and Woodburn J.R. (1990b). Pancreatic secretory trypsin inhibitor stimulates the growth of rat pancreatic carcinoma cells. Gastroenterology 99, 1414-1420.
7. Fritz H., Huller I., Wiedemann M. and Werle E. (1967). On protease inhibitors, V. On the chemistry and physiology of the specific trypsin inhibitors from the ox, dog, pig and human pancreas. Hoppe Seylers Z. Physiol. Chem. 348, 405-418.
8. Higashiyama M., Monden T., Tomita N., Murotani M., Kawasaki Y., Morimoto H., Murata A., Shimano T., Ogawa M. and Mori T. (1990a). Expression of pancreatic secretory trypsin inhibitor (PSTI) in colorectal cancer. Br. J. Cancer 92, 954-958.
9. Higashiyama M., Monden T., Ogawa M., Matsuura N., Murotani M., Kawasaki Y., Tomita N., Murata A., Shimano T. and Mori T. (1990b). Immunohistochemical study on pancreatic secretory trypsin inhibitor (PSTI) in gastric carcinomas. Am. J. Clin. Pathol. 93, 8-13.
10. Higashiyama M., Doi O., Kodama K., Yokouchi H., Tateishi R., Matsuura N., Murata A., Tomita N., Monden T. and Ogawa M. (1992). Immunohistochemical analysis of pancreatic secretory trypsin inhibitor expression in pulmonary adenocarcinoma: Its possible participation in scar formation of the tumor tissues. Tumour Biol. 13, 299-307.
11. Hirahara F., Miyagi Y., Miyagi E., Yasumitsu H., Koshikawa N., Nagashima Y., Kitamura H., Minaguchi H., Umeda M. and Miyazaki K. (1995). Trypsinogen expression in human ovarian carcinomas. Int. J. Cancer 63, 176-181.
12. Hsu S.M., Raine L. and Fanger H. (1981). Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: A comparison between ABC and unlabeled antibody (PAP) procedures. J. Histochem. Cytochem. 29, 577-580.
13. Huhtala M.L. (1984). Demonstration of a new acrosin inhibitor in human seminal plasma. Hoppe Seylers Z. Physiol. Chem. 365, 819-825.
14. Kawano N., Osaw H., Ito T., Nagashima Y., Hirahara F., Inayama Y., Nakatani Y., Kimura S., Kitajima H., Koshikawa N., Miyazaki K. and Kitamura H. (1997). Expression of gelatinase A, tissue inhibitor of metalloproteinases-2, matrilysin, and trypsi[ogen] in lung neoplasms: An immunohistochemical study. Hum. Pathol. 28, 613-622.
15. Koivunen E., Huhtala M.L. and Stenman U.H. (1989). Human ovarian tumor-associated trypsin. Its purification and characterization from mucinous cyst fluid and identification as an activator of pro-urokinase. J. Biol. Chem. 264, 14095-14099.
16. Koivunen E., Saksela O., Itkonen O., Osman S., Huhtala M.L. and Stenman U.H. (1991). Human colon carcinoma, fibrosarcoma and leukemia cell lines produce tumor-associated trypsinogen. Int. J. Cancer 47, 592-596.
17. Koshikawa N., Nagashima Y., Miyagi Y., Mizushima H., Yanoma S., Yasumitsu H. and Miyazaki K. (1997). Expression of trypsin in vascular endothelial cells. FEBS Lett. 409, 442-448.
18. Koshikawa N., Hasegawa S., Nagashima Y., Mitsuhashi K., Tsubota Y., Miyata S., Miyagi Y., Yasumitsu H. and Miyazaki K. (1998). Expression of trypsin by epithelial cells of various tissues, leukocytes, and neurons in human and mouse. Am. J. Pathol. 153, 937-944.
19. Lukkonen A., Lintula S., Von Boguslawski K., Carpen O., Ljungberg B., Landberg G. and Stenman U.H. (1999). Tumor-associated trypsin inhibitor in normal and malignant renal tissue and in serum of renal-cell carcinoma patients. Int. J. Cancer 83, 486-490.
20. Lukkonen A., Sorsa T., Salo T., Tervahartiala T., Koivunen E., Golub L., Simon S. and Stenman U.H. (2000). Down-regulation of trypsinogen-2 expression by chemically modified tetracyclines: Association with reduced cancer cell migration. Int. J. Cancer 86, 577-581.
21. Matsuda K., Ogawa M., Murata A., Kitahara T. and Kosaki G. (1983). Elevation of serum immunoreactive pancreatic secretory trypsin inhibitor contents in various malignant diseases. Res. Commun. Chem. Pathol. Pharmacol. 40, 301-305.
22. Miyata S., Koshikawa N., Higashi S., Miyaga Y., Nagashima Y., Yanoma S., Kato Y., Yasumitsu H. and Miyasaki K. (1999). Expression of trypsin in human cancer cell lines and cancer tissues and its tight binding to soluble form of Alzheimer amyloid precursor protein in culture. J. Biochem. (Tokyo) 125, 1067-1076.
23. Moilanen M., Sorsa T., Stenman M., Nyberg P., Lindy O., Vesterinen J., Paju A., Konttinen Y.T., Stenman U.H. and Salo T. (2003). Tumor-associated trypsinogen-2 (Trypsinogen-2) activates procollagenases (MMP-1, -8, -13) and Stromelysin-1 (MMP-3) and Degrades Type I Collagen. Biochemistry 42, 5414-5420.
24. Ohmachi Y., Murata A., Matsuura N., Yasuda T., Monden M., Mori T., Ogawa M. and Matsubara K. (1993). Specific expression of the pancreatic-secretory-trypsin-inhibitor (PSTI) gene in hepatocellular carcinoma. Int. J. Cancer 55, 728-734.
25. Paju A., Bjartell A., Zhang W.M., Nordling S., Borgstrom A., Hansson J. and Stenman U.H. (2000). Expression and characterization of trypsinogen produced in the human male genital tract. Am. J. Pathol. 157, 2011-2021.
26. Sorsa T., Salo T., Koivunen E., Tyynela J., Konttinen Y.T., Bergmann U., Tuuttila A., Niemi E., Teronen O., Heikkila P., Tschesche H., Leinonen J., Osman S. and Stenman U.H. (1997). Activation of type IV procollagenases by human tumor-associated trypsin-2. J. Biol. Chem. 272, 21067-21074.
27. Stenman U.H., Huhtala M.L., Koistinen R. and Seppala M. (1982). Immunochemical demonstration of an ovarian cancer-associated urinary peptide. Int. J. Cancer 30, 53-57.
28. Terada T. and Nakanuma Y. (1991). Immunohistochemical demonstration of pancreatic alpha-amylase and trypsin in intrahepatic bile ducts and peribiliary glands. Hepatology 14, 1129-1135.
29. Terada T., Kitamura Y., Ashida K., Matsunaga Y., Kato M., Harada K., Morita T., Ohta T. and Nakamura Y. (1997). Expression of pancreatic digestive enzymes in normal and pathologic epithelial cells of the human gastrointestinal system. Virchows Arch. 431, 195-203.
30. Tomita N., Doi S., Higashiyama M., Morimoto H., Murotani M., Kawasaki Y., Monden T., Shimano T., Horii A. and Yokouchi H. (1990). Expression of pancreatic secretory trypsin inhibitor gene in human colorectal tumor. Cancer 66, 2144-2149.
31. Ueda G., Shimizu C., Tanaka Y., Inoue M., Tanizawa O., Ogawa M. and Mori T. (1989). Immunohistochemical demonstration of pancreatic secretory trypsin inhibitor in gynecologic tumors. Gynecol. Oncol. 32, 37-40.
32. Verspaget H.W. (1998). Proteases as prognostic markers in cancer. Br. Med. J. 316, 790-791.